tiprankstipranks
Trending News
More News >
23andMe Holding (MEHCQ)
OTHER OTC:MEHCQ
US Market

23andMe Holding (MEHCQ) Price & Analysis

Compare
1,317 Followers

MEHCQ Stock Chart & Stats


Ownership Overview

41.38%9.28%0.05%49.29%
41.38%
Insiders
9.28%
Mutual Funds
0.05% Other Institutional Investors
49.29% Public Companies and Individual Investors

MEHCQ FAQ

What was 23andMe Holding’s price range in the past 12 months?
23andMe Holding lowest stock price was $0.47 and its highest was $10.82 in the past 12 months.
    What is 23andMe Holding’s market cap?
    23andMe Holding’s market cap is $151.52M.
      When is 23andMe Holding’s upcoming earnings report date?
      23andMe Holding’s upcoming earnings report date is Aug 06, 2025 which is in 51 days.
        How were 23andMe Holding’s earnings last quarter?
        23andMe Holding released its earnings results on May 22, 2025. The company reported -$3.621 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.621.
          Is 23andMe Holding overvalued?
          According to Wall Street analysts 23andMe Holding’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does 23andMe Holding pay dividends?
            23andMe Holding does not currently pay dividends.
            What is 23andMe Holding’s EPS estimate?
            23andMe Holding’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does 23andMe Holding have?
            23andMe Holding has 20,499,552 shares outstanding.
              What happened to 23andMe Holding’s price movement after its last earnings report?
              23andMe Holding reported an EPS of -$3.621 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.321%.
                Which hedge fund is a major shareholder of 23andMe Holding?
                Currently, no hedge funds are holding shares in MEHCQ

                Company Description

                23andMe Holding

                23andMe Holding Co. is a consumer genetics and research company that operates in the healthcare sector. It offers direct-to-consumer genetic testing services, providing customers with insights into their ancestry, genetic health risks, and wellness traits. Through its platforms, the company empowers individuals to access, understand, and benefit from the human genome, thereby promoting personalized healthcare and fostering genetic research.

                MEHCQ Revenue Breakdown

                100.00%100.00%0.00%
                100.00% Consumer & Research Services
                0.00% Therapeutics
                tipranks
                Similar Stocks
                Company
                Price & Change
                Follow
                Myriad Genetics
                Fulgent Genetics
                Burning Rock Biotech
                Biodesix
                Prenetics Group
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis